No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Headquartered in Tokyo, Japan, Qol Holdings Co., Ltd., established in 1992, operates a diverse portfolio of businesses, primarily focusing on dispensing pharmacies and business process outsourcing (BPO) within the healthcare sector. The company establishes its dispensing pharmacies through tailored, trust-based relationships with individual medical institutions. Beyond its pharmacy operations, Qol Holdings provides extensive BPO services, including conducting sales and marketing research for pharmaceutical companies. It also specializes in dispatching temporary staff across various medical professions, such as pharmacists, nurses, registered sellers, and dietitians. Additionally, the company offers comprehensive support for clinical trials involving both pharmaceuticals and food products. This support encompasses a broad spectrum of services, from assisting with trial execution planning and monitoring to providing secretariat support, statistical analysis, and facilitating the presentation of conference papers, often through the dispatch of skilled managers and technicians. The company further extends its offerings to include publishing-related services. Originally named Qol Co., Ltd., the company adopted its current name, Qol Holdings Co., Ltd., in October 2018.
www.qolhd.co.jpNo one on the platform currently holds 3034.T.
No tracked institution reports a position in 3034.T as of their last filing.
No one on the platform has traded 3034.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.2% | 10.0% | 9.6% | — | — | — |
| Rev. Growth % | 10.2% | 12.4% | ||||
| Profit Margin % | 2.5% | 2.8% | 2.8% | |||
| Free Cash Flow Margin % | 5.8% | 5.0% | 4.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $310.0B | +6.2% | $215.60 | $215.60–$215.60 | — | 1 |
| 2028 | $315.5B | +1.8% | $223.50 | $223.50–$223.50 | — | 1 |
| 2029 | $322.0B | +2.1% | $231.50 | $231.50–$231.50 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| +1.43% |
| $59.7B |
| — |
| 4480.TMedley, Inc. | $2380.00 | -1.73% | $71.5B | — |
| 4549.TEiken Chemical Co., Ltd. | $2260.00 | +0.22% | $74.5B | — |
Source: Financial Modeling Prep · peers by sector/industry